Tetracyclines and mineralized tissues: review and perspectives. by Skinner, H. C. & Nalbandian, J.
THE YALE JOURNAL OF BIOLOGY AND MEDICINE 48, 377-397 (1975)
Tetracyclines and Mineralized Tissues: Review and Perspectives
H. CATHERINE W. SKINNER2
Yale University, Department ofSurgery, 333 CedarStreet,
New Haven, Connecticut 06510
AND
JOHN NALBANDIAN
Professor ofPeriodontics, SchoolofDental Medicine,
University ofConnecticut, Farmington, Connecticut 06032
Received May 2, 1975
INTRODUCTION
The tetracyclines have proved to be an extremely important group of drugs be-
cause of their wide range of antibiotic activity (1-3). (For general background, anti-
biotic activity, and pharmacology of the tetracyclines, we refer the reader to recent
review articles by Weinstein (1), Kucers (3), Weisblum and Davies (4), and Garrod
et al. (5).) In addition, they have the unique attribute of being incorporated into
skeletal and dental tissues at sites ofactive mineralization (6-7), where they may be
straightforwardly detected in both whole specimens and sections. Under ultraviolet
irradiation, the tissues exhibit fluorescence-a characteristic intrinsic to the
tetracycline molecule (8).
We will first briefly outline the components, mechanics, and metabolism of the
several normal human mineralized tissues. The chemistry of tetracyclines will be
discussed, followed by the biochemistry, with emphasis on their incorporation into
calcified tissues and the information that such a phenomenon provides. We will
consider mineral-tetracycline reactions, fluorescent labeling of bone and teeth, and
the effects of tetracyclines on mineralized tissues at different levels. Observations
made in our laboratory will illustrate and confirm several concepts found in the
tetracycline literature. There are, as might be anticipated, further avenues of re-
search to beexplored.
MINERALIZED TISSUE DYNAMICS
Mineralized tissues, bones, and teeth, are characterized by an intimate mixture of
organic and inorganic constituents (9, 10). The organic fraction of bone and the
dentin and cementum portions of the tooth organ are predominantly (> 90%) the
asymmetric protein, collagen, plus minor glycoproteins and mucopolysaccharides.
The inorganic fraction is a calcium phosphate whose crystal chemistry most closely
approximates Ca,0(PO4)6(OH)2, the mineral known as hydroxyapatite (HA). The
proportion of inorganic to organic is predictable for particular mineralized tissues
but is dependent on age or maturation level, systemic conditions, and/or any local
pathological considerations for a specific sample. Enamel, the most highly
mineralized tissue in the body (> 98% inorganic) is distinctive in having a noncolla-
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genous protein matrix and becoming acellular at maturity. Bone and cementum, 50-
80% inorganic, normally contain actively metabolizing cells involved in the
formation and remodelling of the tissue in response to growth, nutrition, and
homeostasis. Dentine, about 70% inorganic, has minimal, if any, turnover once
formed, but cells clustered in the pulp cavity have processes (in tubules) throughout
which contribute to tissue viability.
Mineralized tissue formation is known to proceed from specialized tissue cells (os-
teoblasts, dentinoblasts, cementoblasts, ameloblasts) by elaboration of a protein-
mucopolysaccharide matrix, which is extruded from the cell and subsequently
mineralizes. The cells may become enveloped by the calcified matrix they produce,
but they continue to metabolize, providing nutrients and fluid to the tissue from the
blood via a system of anastamosing cell processes within canaliculi. Such cells are
one example of the several different types found in calcified tissues and involved as
functioning units in skeletal dynamics.
Highly mineralized cortical bone at maturity may contain elaborate super struc-
tures called osteons (Haversian systems). Embedded cells are arranged in a con-
centric pattern around a central canal that contains both arteries and venules.
Osteons mature from the circumference toward the canal and may achieve a
diameter of 100 ,um. The structure may be altered or removed in time through
vascular displacement resulting in overlapping (secondary) osteons. Trabecular or
spongy bone may exhibit osteons, in the mineralized spicules of lamellar bone, but
the predominant cell population and activity is concentrated at the interface be-
tween mineralized and unmineralized tissue. Osteoblastic activity or bone formation
(increasing the mineralized tissue mass) may take place side by side with resorption
by osteoclasts, cells that destroy the entire structure (inorganic plus organic). Bone
tissue is dynamic, continually altering structurally both at cellular and intercellular
sites. The rates of formation for bone and teeth and resorption for bone, as well as
the individual cell activity and mineralization of the organic matrix of all calcified
tissues, are influenced by hormones and other circulating factors, such as tetracy-
cline, which will be discussed in this paper.
CHEMISTRY OF TETRACYCLINE
MolecularStructure
Tetracyclines are a family of compounds, basically polycyclic napthacene car-
boxamides (6). The gross structure of oxytetracycline was first determined by
Woodward and collaborators (11) using chemical degradation ofthe compound and
ultraviolet and infrared spectral and analytical techniques. X-ray crystallographic
structural analyses on aureomycin hydrochloride (12) (= chlortetracycline) unam-
biguously demonstrated the concordance with terramycin hydrochloride (oxy-
tetracycline) at the level of the configuration of asymmetric carbon atoms. Simi-
larity in chemical and biological properties presumes this concordance.
The usual chemical presentation ofthe four-ring system oftetracyclines (Fig. 1A)
does not successfully express the fact that the A-ring and its constituents are
rotated with respect to the plane of the B-C-D ring. This structural characteristic,
more obvious in the stereochemical presentation (Fig. 1B), is probably essential for
the stability and activity of the molecule. Epimerization at C4, which takes place
rapidly under acidic conditions, results in almost complete loss (95%) of activity
(13). The appropriate configuration of substituents on the A-ring is critical for anti-
biotic activity (14). The OH on C6 (C-ring) is highly labile, responding to both acid
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FIG. 1. (A) Tetracycline molecule with areas of potential metal cation chelation in boxes. (B) Stereo
configuration oftetracycline after Donahue et al. (12).
and basedegradations (6); this will lead to a relative loss ofactivity, as do any substi-
tutions on theC1, or C12 atoms (6). Investigations into the tetracycline molecule (15)
and its biosynthesis (16) have shown that the hydroxyl on Ci2ais present early in the
pathway and required for antibiotic function. In general, it has been demonstrated
that structural variations at the Cii, C12, Ci2a, C6, C5, and C4 sites may result in a
loss ofin vitro antibiotic activity ofthe molecule.
Molecular Reactions
No specific protein binding site has been designated on the molecule, but tetracy-
clines complex with aliphatic/carboxylic acids or urea derivatives in the molecular
ratio of two tetracyclines to one (17). Further, the sites enclosed in boxes in Fig. IA
have been implicated in cation binding, which is ofimportance to in vivo antibiotic
activity (18, 19). Electronic interaction is possible between these sites, from which it
is inferred that complexation could take place at either or both. Mutual dependence
and/or enhancement of cation binding for optimum molecular fit (and activity) in
vivo is reminiscent of the stereochemical configurations "required" for enzyme
catalysis (20). Modification of the basic molecule or of substituents to maintain
molecular stability while maximizing antibiotic characteristics is only one aspect of
the activity in vivo (6). Chemical and structural environment of the reaction site is
probably equally important in theefficacy ofthese compounds as antibiotics (21).
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Fluorescence ofthe Molecule in the Presence ofCations and/or
Proteins and Its Stability
Table 1 presents the absorption and emission (fluorescence) spectral maxima we
observed on tetracycline hydrochloride and tetracycline hydrochloride in associa-
tion with CaCl2, FeCl2, and FeCl3 in methanol solutions. The inherent fluorescence
of the tetracycline molecule is enhanced in the presence of CaCl2 and decreased in
the presence of both FeCl2 and FeCl3. A definite shift in ultraviolet absorption
maxima was observed only at high CaCl2 concentrations (10-2 M). Low concentra-
tions (10-5) ofthe cations were used for comparison fluorescence and absorption to
minimize interference by Fe, which is obvious at higher concentrations. No
significant changes in absorption maxima or fluorescence were noted even after 4
days of cation association with the tetracycline hydrochloride. The solutions were
kept in the dark at low temperatures during that time. The ultraviolet absorption
maxima determined by us for tetracycline hydrochloride are very similar to those
given by Conover et al. (22) (seeTable 1).
Tetracyclines are amphoteric and soluble in aqueous bases or acids. Acid
tetracycline salts readily dissolve in most organic solvents (6) giving high
fluorescence. The fluorescence oftetracyclines increases with the quantity ofethanol
in solution concomitant with a blue shift ofthe fluorescent maxima (23). A slight red
shift of the fluorescent maxima is found with metal cation-tetracycline complexes
(23) (see Table 1). Increased fluorescence directly proportional to the concentration
of magnesium (Mg) has been demonstrated (20). The presence of Mg ions enhances
the fluorescence oftetracycline bound to ribosomes (24). Complexes ofcalcium and
tetracycline show fluorescence (25, 26), which increases with concentration but not
TABLE 1
Ultravioleta and Fluorescence Data on Tetracycline Hydrochloride and Tetracycline
Hydrochloride + Metal Chlorides
Ultraviolet Fluorescence
Sample X maximum v X maximum 2; (relative I)
TC
- HCI in MeOH Conover, 1953 (50) 363 13 800b 268 18 600b N.D.
TC
- HCI 370 13 742 273 15 857 24
after4 days 370 13 646 273 16 145
TC * HCI + CaCl2 10-2 377 15 760 277 14 031
after 4 days 400 15 760 280 14 799
TC
- HCl + CaCI2 10-5 370 14 031 273 15 760 60
after 4 days 375 13 646 273 14 992
TC
- HCI + FeCl2 10-5 370 14 031 273 16 337 10
after4 days 370 13 262 273 19 220
TC * HCI + FeCI3 10-5 373 14 031 273 15 953 10
after 4 days 373 12 493 273 16 145
TC * HCI + CaCl2 10-5 + FeCl2 10 5 373 14 031 275 16 145 45
after 4 days 375 12 685 274 16 337
TC
- HCI + CaCl2 10-5 + FeCl3 10-5 373 13 646 275 16 145 43
after 4 days 373 11 916 273 15 568
aAll analyses by Elaine Yamaguchi, Department of Chemistry, Yale University. Ultraviolet de-
terminations were made using Beckman grating Spectrophotometer Model No. DBG, L (extinction
coefficient) = A (absorption)/(C X 1) (cell length = 1 cm). Relative intensity of fluorescence was de-
termined on Jarrell Ash Model 82-410 Fluorescence Emission Spectrometer at OD = 0.1 using
quinine bisulfate (MW = 548.6) as standard. Values have been rounded to nearest whole number and
did not change appreciably over the 4-day period.
bConverted from log v (50).
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in a linear fashion. There is a drop in fluorescence at high calcium concentrations
(10-2 M) (23). Fe3+-plus-tetracycline complexes are not photochemically active (27).
Examination of metal cation (Me)-plus-tetracycline (TC) precipitates are consistent
with the metal ion occupying an octahedrally coordinated site (19) in the solid. A
general formula for the complex Me(TC)2(H2O)2 assumes that tetracycline is a bi-
dentate group (19).
The association of iron plus tetracycline in aqueous solutions, especially Fe3+,
shows high stability, several orders of magnitude higher than other metal complexes
(28). Heinrich and Oppitz (29) have shown that tetracycline inhibits iron absorption
in man. The bacteriostatic activity of the drug in serum fell during ingestion of iron
by patients. In view of the requirements of iron to sustain bacterial growth (30),
perhaps part of the antibiotic activity of tetracycline is related to the formation of
iron-tetracycline complexes, lowering the level of iron available to bacteria. Iron
complexation (18) might explain the response of the gastrointestinal flora to
tetracycline ingestion and the rapid reversibility of the effects upon cessation of use.
Cation complexation and inhibition of protein synthesis could reduce bacterial pro-
liferation. Radioactive tracer compounds might be useful to discriminate between
mechanisms of action.
Complexes of tetracyclines and bovine serum albumin also exhibit enhanced
fluorescence and a blue shift (23). Ten to 20 times higher fluorescence (quantum
yield) has been found for tetracyclines in hydrophobic environments than in any of
these solvents (31). Caswell (32) and others (33) have used tetracyclines as fluores-
cent probes, monitoring changes in divalent cation distribution in mitochondrial
membranes, which upon energization, permit transport ofions.
MINERAL-TETRACYCLINE REACTIONS
In vitro studies show that crystals ofCaCO3 and HA bind tetracycline and exhibit
fluorescence (34), but CaSO4- 2H2O or CaHPO4, 2H2O crystals do not (35). In the
latter two cases, calcium is in a different crystal structural configuration which
may make it less available to chelation by the tetracycline molecule. The formation
of the normal inorganic mineral phase in statoliths and nematocysts, CaSO4 -2H2O,
is inhibited by the presence of tetracycline, but tetracycline is not incorporated (35).
Precipitation of HA is also inhibited by tetracycline, but high concentrations are re-
quired (36). At lower tetracycline concentrations, HA crystals, especially those with
a Ca/P ratio of 1.61 (less than stoichiometric HA, 1.67), incorporate tetracycline in
higher proportions than fully formed HA crystals exposed to tetracycline-
containing solutions (36). Tetracycline also has been shown to inhibit the transition
ofamorphous to crystalline apatite (37).
A possible stereoconfiguration of tetracycline binding to HA has been proposed
(38). The regions of the tetracycline molecule implicated in metal cation binding
were outlined in Fig. 1A. Perrin (38) oriented the tetracycline molecule to superpose
three calcium ions of the HA structure if HA is viewed in the c-axis projection (Fig.
2). Tetracycline replaces two P04 ions. The "O" of the C10, C12, and C2 of tetracy-
cline can "fit" three calcium ion positions of HA with minimal distortion while
maintaining electric neutrality of the complex. The complex "presents" an
essentially hydrophobic surface to the environment (38) minimizing dissociation in
aqueous media. If the suggested orientation of bound tetracycline parallels the "c"
axis of HA (the third dimension), the effect may be to substitute for part of the
structure as depicted in Fig. 2.
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FIG. 2. Suggested association oftetraycline on the lattice ofhydroxyapatite, after Perrin (38).
Anorganic bone, alcohol-ether extracted bone (39, 40), or excised dead bone (41)
will exhibit fluorescence after soaking in tetracycline solutions, whereas bone treated
with EDTA before or after tetracycline soaking will not fluoresce (39). Un-
mineralized osteoid does not exhibit fluorescence (42), and in vitro studies confirmed
that although collagen can bind tetracycline, the complex does not fluoresce (34).
However some noncalcifying, fast growing tissues (nails, hair, tumors, and wounds)
will fluoresce after long periods oftetracycline ingestion (39, 43).
TETRACYCLINE AS AN IN VIVO LABEL
The tetracyclines have been employed as antibiotics for various infections ofbony
tissues (44) and arthritic joints (45) and as a prophylactic measure preceding or-
thopedic surgery (46), where selective localization in bone might aid their clin-
ical effectiveness. However, it is the application in studies of skeletal dynamics that
makes the tetracyclines a particularly exciting and unique class ofdrugs. Tetracy-
clines have a distinctive nonantibiotic use as a fluorescent probe specific for areas
offorming hard tissues (47, 48).
By combining ultraviolet microscopy with autoradiography (45Ca, 14C, 3H), mi-
croradiography, or dyes such as Alizarin or lead acetate, it has been shown that
tetracyclines localize at the site ofdeveloping hard tissues, both in the skeleton (48-
55) and in the teeth (56-62). Tetracycline localization is demonstrated by the
characteristic golden fluorescence of the intact hard tissues irradiated with ul-
traviolet light (63). The fluorescence is qualitatively identical to that of the tetracy-
cline solutions described above and in Table 1. The tetracycline derivative as well as
the specific inorganic species influences the color and intensity of the fluorescence
(64).
In the design of in vivo studies on hard tissues, careful attention is given to the
choice oftetracycline derivative and thedose, duration, and mode ofadministration,
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in order to minimize nonspecific binding and to obtain maximum fluorescence
without disrupting mineralization. A lag time (2-3 days) to clear excess drugs is
usual before excision of tissues (64, 65).3 Optimal preparative procedures of the ex-
cised tissue (67) to retain distinct fluorescent label with minimal artifact suggests
freeze-drying or immersion ofthe sample in alcohol (48, 68). Thegolden ultraviolet-
induced fluorescence of the tetracycline-labeled areas is easily distinguished from
autofluorescence of the tissue (49, 69). Comparison of the section exhibiting
fluorescence with its microradiograph unambiguously defines forming mineral areas
and is probably cautiously wise methodology (48) in using the label for quantitative
measurements ofbone formation.4
Embedded samples have shown no diminutition offluorescence after 6 yr (42), but
there is evidence of some fading in bulk samples stored at room temperature and ex-
posed to light (42). Photochemical oxidation of tetracyclines producing brown or
yellow discoloration can be observed in some samples (43). Chemical changes after
excision, such as degradation of the organic constituents in a sample, incomplete
dehydration, or uptake of water from the atmosphere by the sample may also
contribute to fading or loss ofthe tetracycline label (74).
Histological examination ofundecalcified sections has shown that the tetracycline
label does not cross osseous lamellae, cement, or other incremental growth lines
(48). The width of a tetracycline label, besides depending on the duration oftetracy-
cline ingestion and rate of mineralization of the organ at the site of sampling, is a
function of the angle or direction of sectioning (75). Tetracycline marks all areas of
active hard tissue formation (76) and, therefore, with appropriate experimental de-
sign and control, can be used reliably and accurately to determine the rate of hard
tissue formation.
Tetracycline Label in Bone
Figure 3 illustrates tetracycline label in a ground section of bone as seen with ul-
traviolet microscopy. This specimen is a portion of rib from a normal dog given
several doses of tetracycline intravenously. Each dose of tetracycline incorporated
into a growing Haversian system produces a fluorescent circle conforming to the
osteonal pattern. Calculations of accretion rates for bone have been devised by
several investigators (70, 77). Frost and his collaborators have examined tetracy-
cline-labeled rib and iliac-crest biopsies from normal individuals and patients with a
variety of skeletal disorders. In a series of papers (77-85), bone dynamics for
3A small proportion of the tetracycline label incorporated into bone may be recycled and redeposited
(66) during this short cessation period.
4A typical protocol to obtain sharp tetracycline labels on forming mineralized tissues in adult animals
is intravenous or intraperitoneal administration oftetracycline at a dose of 20 mg/kg ofbody wt/day for
3-6 days with cessation before excision of about 1 week. The time course depends on the purpose of the
study and the metabolism of the patient or animal. After excision, soak the sample in 100% alcohol,
embed, and section. Section thickness, dictated by the topic under investigation, may range from 10 to 12
gm to study high fluorescent single osteons, to 100 rm, for poorly labeled lamellar or woven bone. Ul-
traviolet, or white light with appropriate filters (Wratten 18a, 47, or 47a, between microscope and light
source and Wratten 8, 9, or 2b or Illford 108 in the eye piece) (52, 70), provides the excitation wave length,
approximately 360 cm-' necessary for generating tetraycline fluorescence (6, 48, 41). Bone
autofluorescence may be blue, white, or green depending on the filter system. Variations in the yellow
color of tetracycline fluorescence, golden with chlortetracycline and green-gold with oxytetracycline,
have been used to good advantage: one tetracycline to label the control, the other to label the experi-
mental period (70). In other sequential studies more than two tetracycline varieties have been used,
together with dyes (72). Some variations in shade offluorescence may be related to the dose.
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FIG. 3. Ground section; of rib bone from a normal dog given several doses of tetracycline
intravenously. (A) Viewed with transmitted white light. (B) The same area under ultraviolet light shows
three osteons, each with two fluorescent rings (dark circles). x 175. Photographs courtesy of Dr. J. P. Al-
bright.
different metabolic situations have been discussed. Quantitative histological
methods are applied to bone labeled in vivo with tetracycline. The rate offormation
and quantity ofbone within Haversian systems are measured. The cellular activity in
several sections (number of cells actively metabolizing) are calculated and the re-
sults extrapolated to the organ level. Differences in bone activity at the several levels
of resolution were observed and calculated between samples from patients and age-
matched normals. These detailed investigations have led to suggestions on the form
or type and on the level of the metabolic abnormality in patients. Disease states
investigated by this group include: osteoporosis (78), osteomalacia (79),
pseudohypoparathyroidism (80), acromegaly (81), primary hypophosphatemic
rickets (82), osteogenesis imperfecta (83), osteopetrosis (84), and pycnodysostosis
(85). The effects of fluoride (86) and acetyl salicylic acid (aspirin) (87) on bone have
been investigated. In an editorial (88) that includes details of the methodology, the
systematic errors and the distinction between cellular, tissue, and organ level dy-
namics, Frost presented averaged appositional rates for Haversian remodelling,TETRACYCLINE AND MINERALIZED TISSUES
1.5-0.72 ,um/day5 in the normal rib, for periods from birth to age 89. Time for
osteon formation over the same age range and grouping was 0.13-0.30 yr/osteon
and a bone (rib, cortical) formation rate of0.85-0.044 mm2/mm2/yr.
Tetracycline labeling of bones from normal animals has been used to confirm
variable rates of bone formation within a bone at the level ofindividual osteons (89)
and between trabecular and cortical bone (88). The thickness of osteoid seams has
been estimated using the usual histologic techniques (90). Differences at the organ
level, rib versus femur (34, 91) at the intraorgan level, metaphysis versus diaphysis
(92), and the complicated cell-mediated-metabolic control of skeletal dynamics
were known but perhaps insufficiently appreciated before the advent oftetracycline
as a unique bone-seeking label and quantitative histological examination of bone
biopsies (88, 93).
Tetracycline Labelin Teeth
Although the use of tetracycline antibiotics has been curtailed, especially for the
young, past use and incorporation in dental hard tissues are readily apparent. A re-
cent article (94) graphically illustrates both the visible and the ultraviolet light
macroappearance of tetracycline-affected whole teeth. Examination ofground sec-
tions of teeth that have incorporated tetracycline show sharp bands, permanent
records of the specific time and duration of tetracycline ingestion (61). A
voluminous literature exists on tetracyclines and human teeth (95-103), especially
describing adverse cosmetic effects of the altered tooth enamel and fluorescent
banding observed in ground sections. Most specimens gathered and studied have
only one or a few bands. Weyman (95) reported from one to five bands per tooth in a
series of30 patients. Baker (104) reported on fluorescent bands in crowns. In a study
of83 teeth, 14 ofthe most seriously affected specimens averaged 8.9 lines per tooth.
Observations on Tetracycline in a Tooth Section
We obtained specimens of maxillary and mandibular third molars that must be
almost unique.6 Sixty distinct bands oftetracycline were observed within the dentin
of a longitudinal ground section of the maxillary molar (Fig. 4). A regimen of oral
tetracycline (Sumycin) in the usual dose range, repeated at intervals by this adoles-
cent female virtually throughout the entire period of tooth gestation, resulted in
serial incorporation expressed as individual bands. The tooth was anatomically well
formed and virtually normal in color, lacking gross hypoplastic effects and having
no obvious reduction in size. Under ultraviolet excitation, the yellow fluorescent
bands in the section are striking. The two bands in the cuspal dentin (d) of the
specimen (Fig. 5A) can be traced and shown to correspond developmentally to two
bands in the enamel (e) by confluence at thedentino-enameljunction (DEJ) (Fig. 5A,
arrow). In the dentin, the rootward bending of bands at the outer edge of the tooth
crown, faithfully following the DEJ, as well as band curvatures in the more central
part of the tooth, depicts the normal incremental pattern of dentin formation and
mineralization (105). A few ultraviolet bands correspond to lines noted on the
section when viewed with ordinary white transmitted light, indicating some local
variations in mineralization. The width of most bands at the site of least sectioning
-For details of calculations and rationale of the extrapolation from sequentially labeled Haversian
systems to whole organ dynamics, the reader should consult the Frost articles, in particular (88).
8Courtesy of Dr. Stanton Fater, D.D.S., New Haven.
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FIG. 4. A ground section of a maxillary third molar from a 19-yr-old female known to have taken
repeated oral doses of tetracycline. (A) Photographed with ultraviolet light. Bands of tetracycline
fluorescence are prominent in the dentin. Enamel shows marked fluorescence near the DEJ. x 10. (B)
Photographed with transmitted white light. Incremental lines are visible in the dentin and enamel, corre-
sponding to tetracycline bands. x 4
distortion measured approximately 35 ,um, which we infer corresponds to the period
ofingestion of tetracycline (12 days). The 35,um value is exceedingly constant in the
sample (except for a few narrower bands) and corroborates the rate of growth of
dentin in molars postulated by Schour and Poncher (106), approximately 3 zm/
day.7
Microscopic observations ofthe tooth section shown in Figs. 4 and 5 show several
prominent lines of Retzius in the enamel and Von Ebener's lines in the dentin and
some, but not an unusual amount of, interglobular dentin. These incremental lines
corresponded to fluorescent bands seen with ultraviolet light. The following more
detailed observations were made: (a) The pulpal aspect ofthe fluorescent bands was
less sharply demarcated as compared to the peripheral side (Fig. 5). This and many
of the following observations are expected, based on our knowledge of tooth
embryology and the pharmacology of tetracyclines, and have been reported by
others (45, 100, 107). (b) On close inspection, the bands often resolved into scalloped
configurations (Fig. 5B) as if tetracycline incorporation occurred at the proximal
surfaces ofglobules ofcalcification. In some cases the entire periphery of a globule
was fluorescent. By first locating a globule under ultraviolet light, it was possible to
revert to ordinary transmitted light and pinpoint the same globule, recognizing a
subtle difference in the optical property of the dentin not readily distinguishable. (c)
Some interglobular dentin revealed fluorescence even when not situated along the
fluorescent bands. (d) The dentinal tubules showed a constant degree offluorescence
along their entire length. No disturbance, distortion, bifurcation, or blockage ofany
tubule was seen anywhere in the section examined by us. Observations to the
7The actual data given by Schour and Poncher (105) are for deciduous teeth; enamel, 3.9 Am/day;
dentin, 3.8 Am/day; and permanent tooth enamel, 2.7 um/day. We extrapolate that permanent dentin ac-
cretion should be somewhat less than 3 Am/day.
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contrary have been recorded (108) and may very well depend on the individual dose
level, total quantity ingested, and type oftetracycline. (e) The cementum was highly
fluorescent throughout, with several bands distinguishable. (f) The two bands in the
inner enamel had considerably reduced intensity relative to their corresponding
dentin bands (Fig. 5A). The same was true for several short, faint bands seen in the
cervical enamel, corresponding to a later series ofdentin bands. Possible reasons for
this difference are discussed below. (g) The most prominent fluorescence in the
enamel was located along the DEJ with extensions outward in a pattern corre-
sponding to Hunter-Schreger bands. The fluorescence was rather disseminated and
diffuse. There was no fluorescence in the dentin that could be unambigously defined
as corresponding to this zone in the enamel. (h) Enamel lamellae, tufts, and spindles
also revealed some degree of fluorescence, with the spindles generally brighter than
their dentinal counterparts.
Tetracycline Fluorescence in theSeveral Mineralized TissueSystems
As confirmed in our tooth specimen (Figs. 4 and 5), tetracycline bands in the
enamel exhibit less fluorescence than those in thedentin, or else they tend to be more
diffuse (96, 104, 109). This may be related to differences in the development of the
two tissues. With dentin, a small amount of matrix (predentin) is formed and then
calcifies quite abruptly. In enamel, the initial influx of mineral into the matrix repre-
sents only a fraction ofits ultimate complement, and there is a prolonged process of
maturation as crystallites increase in size. Enamel crystals at maturity are several
times those found in dentin. The smaller-size HA crystals in dentin imply greater
surface area and presumably a larger number of potential tetracycline binding sites
(25). There are other possible differences. The enamel mineral phase is distinct from
that of dentin and bone not only in size and rate of formation but in composition
(110, 111). Enamel not only has a higher proportion ofmineral to organic matrix but
the composition ofthe organic matrix is different from that in dentin and bone.
Examination of adult rat teeth and bone after tetracycline injection (109) showed
that the incisors were more highly fluorescent than rat femurs. This is a demon-
stration of basic differences in response to tetracycline of two normal mineralized
tissues and organs. Over a period oftime, fluorescence in bone will diminish and vir-
tually disappear, since bone tissue is a dynamic cellular system that not only de-
posits but may resorb and redeposit the extracellular material over a period oftime
within the organ. In fact, evidence has been presented to suggest that tetracycline
deposited in the skeleton may be released in the course of remodelling, reenter the
circulation, and be incorporated in other hard tissues, dentin, for example (66).
Enamel and dentin, on the other hand, are not normally reworked (at the tissue
level) once formed; hence, the initial tetracycline label is effectively permanent. The
mechanisms of localization and concentration of tetracycline are probably dis-
tinctive for each ofthe calcified tissues.
THE NONFLUORESCENT EFFECTS OF TETRACYCLINE IN
MINERALIZED TISSUES
The administration of tetracycline for antibiosis always presents a risk ofdisrup-
tion of the mineralizing skeletal tissues, although small for most instances. There is
probably little way of distinguishing between the disruption of calcified tissues
FIG. 5. Higher magnification ofportions ofthe tooth in Fig. 4A. (A) Two adjacent fluorescent lines in
the dentin (d) converging (arrow) with less intense enamel (e) lines. x 20. (B) Wavy or saclloped tetracy-
clinelines and tetracycline outlining dentinal tubules (perpendicular to tetracycline lines). x80.
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caused by tetracycline and that due to concomitant fever or other problems related
to the disease for which the antibiotic has been prescribed. At the cellular level, espe-
cially in bone where the structural evidence is not sequentially laid down, thedisrup-
tions may be destroyed (reworked) in time. It is estimated that the average lifetime
ofhuman bone tissue is 10 yr (112), but as mentioned above, the period offormation
of specific structures (Haversian systems or osteons) is of the order of days to
months (88, 111). The effects of tetracycline as well as traumatic systemic events
can be examined long after their incorporation in the mineralized tissue (114). For
example, the event ofbirth will be recorded in the developing teeth ofthe fetus (115).
Examination of the deciduous teeth years later, after exfoliation, may permit ob-
servation of this event. The ingestion oftetracyclines by an expectant mother, or by
any individual, is permanently recorded in teeth undergoing active formation at the
time of ingestion. There is a distinct advantage in studying teeth to determine the
nonfluorescent aspect oftetracycline incorporation in mineralized tissues.
Adverse side effects ofthe human use ofthe drug, such as tooth discoloration and
hypoplasia, are the result of tetracycline administered during the period of dental
development (47, 103). The relationship of tetracycline to incidence of caries (101-
103) and the devastation of the whole tooth organ with continual high doses of
tetracycline, such as those required in treatment of systemic diseases, for example,
cystic fibrosis (116) (see Fig. 6), have prompted in-depth studies of the effects on
teeth. Ultraviolet light, and electron microscopy, microradiography, and other
more subtle techniques (104, 117) have been utilized.
Gross examination of tetracycline-affected human enamel (104) showed (a)
hypoplasia associated with fluorescence, (b) tooth discoloration related to the
intensity of the fluorescence and the number of microscopically demonstrated
tetracycline episodes (bands) in the dentin, and (c) a lower specific gravity and mi-
crohardness for the severly discolored areas ofenamel. X-ray microradiographs on
tissue sections confirm the correlation ofhypoplasia and the location oftetracycline
fluorescence.
Ultrastructural studies on rat enamel by Omnell et al. (109) and Nylen et al. (117)
have shown that hypomineralized increments can be produced with single dose (30-
130 mg/kg body wt) and gross hypoplastic lesions with multiple (intraperitoneal) in-
...~ ~~ ~~~~~. .. ... ... ..... ...........................
FIG. 6. Permanent tooth discoloration and hypoplasia in a patient who was treated with tetracycline
forcystic fibrosis during thedental development period.
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jections of tetracycline. There were disturbances in packing and organization of
enamel prisms sometimes persistent beyond theperiod oftetracycline ingestion. Re-
duction in number, size, shape, and location ofcrystals, absence of mineral relative
to organic, or the inverse, a hypermineralized layer, were the more drastic effects
directly related to the size of the dose and/or multiple injections. Occasional areas
of dense crystals were found, and within tetracycline bands, crystallites of thicker
size were observed, relative to those outside the bands at the same developmental
stage. Dense crystalline aggregates were also found along the DEJ, an otherwise
normal area, adjacent to tetracycline bands. All are examples of a generalized dis-
ruption of mineralization. It is obvious that tetracycline ingestion, especially in high
doses, interferes with normal enamel formation.
INTERPRETATION AND INTEGRATION OF THE OBSERVATIONS-
A TETRACYCLINE "EFFECT"
The fact that enamel possesses a high degree of structure that is known in detail
(118-121) enables differences in development to be recognized. Examination of
dentin has not shown such striking morphological discrepancies between unaffected
and affected teeth (96) except that at high doses dentinal tubules may be disrupted
(108). Fluorescence is usually more prominent in dentin (not in predentin) than cor-
responding bands in the enamel (109). Enamel fluorescence may be weak or absent
and observed only with multiple injections oftetracycline (109) or a high initial dose
(117). The wavy structure of tetracycline bands in enamel and globular outlines in
dentin support the suggestion that tetracycline incorporation is contemporaneous
with ingestion and contiguous for the entire formative zone in thesetissues. Further,
since interband areas can be structurally normal and nonfluorescent, some of the
tetracycline localization in mineralizing tissues is probably directly related to
specific cellular activity.
The stage in the cycle of a cell, elaboration of matrix or maturation of that ma-
trix, may be critical to the degree or level oftetracycline interference. Perhaps there
are times when cells are more susceptible to tetracycline or perhaps the effects ob-
served are more striking. Major morphological disruptions within the tooth organ,
of dentinal tubules or enamel prisms, suggest interference at the time of matrix
formation. The effect may be in the mode described for antibiotic action: "interrup-
tion of the elaboration of protein." The effect appears reversible for most tetracy-
cline derivatives, provided the (adult human) dose is less than 1 g/day (ap-
proximately 10 mg/kg body wt) and of a duration less than 2 weeks. The dose
threshold for morphologic disturbance may be distinctive from the dose affecting
crystalline maturation. Maturation interference may be expressed as a hypoplastic
or hyperplastic layer. A hypoplastic layer will be observed only if the sample is ex-
cised and examined a short time after the tetracycline insult or if the cell does not
complete maturation in the area. The hypoplastic layer may be reworked, especially
in enamel (117), and a hypermineralized zone may be formed following tetracycline
insult.
The metabolism of tetracycline by the cell is influenced not only by the amount
but by the variety and the method of administration (122-124). Subcutaneous and
certainly oral doses of the antibiotic may circulate longer than an intravenous in-
jection, although the latter mode would achieve higher blood concentrations most
rapidly. The severity of the effects of tetracycline, intensity of fluorescence, and
width of fluorescent bands are related to the variety of tetracycline, size of dose,
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mode of delivery, duration of ingestion, and specific metabolic stage and physical
and chemical environment of the cells. The effects are unique for each mineralizing
tissue.
CONCLUSIONS AND DISCUSSION
The proposed mechanisms ofantibiotic action oftetracyclines are at least twofold
(bifaceted) and related to the stereochemistry of the molecule (125, 131): (a)
Tetracycline sterically inhibits the elaboration of normal bacterial protein by
binding to the 30 S ribosome. (b) Other sites on the tetracycline molecule may che-
late metal cations essential for bacterial cell metabolism, thereby depressing
growth. Both "activities" are potentially reversible for a bacterial population, and
the sensitivity ofa specific bacterial stain within the population may partially depend
on the stage of the bacterial cell cycle as well as the titer and transport characteris-
tics ofthe particular tetracycline derivative.
Partition, concentration, and fixation of tetracycline at the site of forming
mineralized tissues may also be a combination ofthese two molecular level options.
The "blast" activity ofthe several mineralizing cell systems rapidly synthesizes pro-
tein in the early stages, elaborating matrix. Matrix can become "deranged" mor-
phologically in the presence of tetracyclines (although derangement can also be
caused by other factors). The degree of derangement is related to the level, timing,
and duration of the tetracycline dose. Mineralization of the matrix of vertebrate
hard tissue is inhibited in the presence of tetracycline (132) and is thought to be due
to the tetracycline chelation of calcium. The "incorporation" of tetracycline with
specific mineral species, CaCO3 and HA, has been documented and may be essential
to the mechanism by which tetracycline is "fixed" in mineralized tissues.
Tetracycline presence in tissues can be detected by the characteristic golden
fluorescence, an intrinsic property of the molecule and certain metal-tetracycline
complexes, on ultraviolet excitation. It has been shown that tetracycline is a specific
label for actively mineralizing sites in hard tissues. Collagen can bind tetracycline in
vitro, but the fact that unmineralized osteoid (in vivo) fluoresces only immediately
after the dose, not following a period of cessation, begs the question of whether
tetracycline is complexed to osteoid in a minimally or nonfluorescent form (Fe3+ +
TC, perhaps) or not at all. Excised bone and dead bone soaked in tetracycline solu-
tions exhibit the fluorescent label on exposed surfaces.
We can speculate that the rapid collagen synthesis stage (which has Fe2+ as
cofactor) (132) of "blast" cells in mineralizing systems may be effective in concen-
trating tetracycline from the serum. The presence oftetracycline may interferewith
the elaboration of protein either producing an "abnormal" collagen or by altering
the rate. In the formation ofthe extracellular matrix, some tetracycline may be car-
ried along or additional extracellular tetracycline may become associated with the
matrix. Calcium ions at the site of mineralization may be chelated by the ex-
tracellular tetracycline, and any crystallites forming on or within the collagenous
matrix may be the foci for tetracycline incorporation. A Ca-plus-tetracycline com-
plex is stable and would remain until the entire structure of the tissue, organic and
inorganic, disintegrates or is reworked.
The concentration of tetracycline taken up by the different mineralizing cell
systems-enamel, bone, or dentin-may be a reflection of the distinctive protein
produced by these systems (and cofactors required) and/or the amount of calcium
or other ions available for chelating tetracycline. The permanence ofthe tetracycline
is dictated by the biology of the cell system (i.e., absence ofremodeling). Differential
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fluorescence in tissues implies differences in the particular hard tissue system and in
the amount of tetracycline available. However, lack of fluorescence should not be
taken as assured absence of tetracycline, i.e., fluorescence is an inadequate base on
which to establish a quantitative assay for tetracycline (134-136).
Future work elucidating the precise metabolism oftetracycline, as well as concen-
tration and localization (immobilization) mechanisms, must be undertaken. Fur-
ther, the effects of tetracycline on different mineralizing cell systems so precisely
documented morphologically on enamel should be extended to dentin and bone. In-
tegrating the tetracycline biochemistry with morphological effects will add insight to
our understanding of the chemical reactions of mineralizing systems at the cellular
level. This knowledge is basic to, and will complement and extend, theelegant use of
tetracycline as a "tree ring" marker in interpreting the kinetics ofbone metabolism.
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